CS Medica is a Danish MedTech company, dedicated to pharmaceutical research, development, manufacturing, and worldwide commercialization. The company blends science and nature to improve patients' lives with cannabinoid therapies for pain relief and addressing autoimmune and stress-related symptoms. Globally, CS Medica offers over-the-counter (OTC) CBD treatments, including patented medical products, MHRA, and MDR-registered items, marketed under the brand CANNASEN® or with its own labeling.

Quotes for CS MEDICA A/S

Right Now

+/-
-0.7
%
−17,07%
Latest
3.4
High
4.08
Low
3.3
Volume
39 402
Turnover (DKK)
141 654
Market Value (MDKK)
41,9
Time (Latest trade)

Board

CEO

  • Lone Henriksen

Chairperson of the Board

  • Jørgen Flemming Ladefoged

Board

  • Anders Permin
  • Gitte Lund Henriksen
  • Karsten Adelmark

Largest Owners

Name Capital % Votes % Date
Lone Henriksen 33,87 33,87 2024-04-25
Gitte Henriksen 32,88 32,88 2023-12-31
Finn-Ove Henriksen and Nina Henriksen 3,34 3,34 2022-06-30
Diaz Capital Invest AB 3,16 3,16 2022-08-24
Ylber Rexhepi 2,32 2,32 2022-06-30
Tonoy Sayeed 1,46 1,46 2022-06-30
Michael Kaa Andersen 1,18 1,18 2022-06-30
Tobias Ryde 1,10 1,10 2022-06-30
Kent Eklund 1,03 1,03 2022-06-30
Taulant Bara 1,03 1,03 2022-06-30
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-05-30 Årsstämma 2023

  • 2024-08-16 Delårsrapport 2024-Q2

  • 2024-11-14 Delårsrapport 2024-Q3

  • 2025-02-14 Bokslutskommuniké 2024